Evidence map›Paper›PMID 26786103›Full record

ArticleThe Journal of biological chemistry2016

Epigenetic Regulation of the Blimp-1 Gene (Prdm1) in B Cells Involves Bach2 and Histone Deacetylase 3.

Hiromu Tanaka, Akihiko Muto, Hiroki Shima, Yasutake Katoh, Nicolas Sax, Shinya Tajima, Andrey Brydun, Tsuyoshi Ikura, Naoko Yoshizawa, Hisao Masai and 5 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 76 citations in OpenAlex.

  1. B cells in cancer: functions, mechanisms and therapeutic advances.Signal transduction and targeted therapy · 2026
    Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Blimp-1 Upregulation by Multiple LigandsFrontiers in pharmacology · 2022
    Article
  16. Article
  17. Review
  18. Protocol forSTAR protocols · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 2 countries.

Hiromu TanakaFrom the Department of Biochemistry and the Department of Pediatric Surgery, Tohoku University Graduate School of Medicine, Seiryo-machi 1-1, Sendai 980-0874.
Akihiko MutoFrom the Department of Biochemistry and CREST, Japan Science and Technology Agency, Seiryo-machi 2-1, Sendai 980-8575.
Hiroki ShimaFrom the Department of Biochemistry and CREST, Japan Science and Technology Agency, Seiryo-machi 2-1, Sendai 980-8575.
Yasutake KatohFrom the Department of Biochemistry and Center for Regulatory Epigenome and Diseases,Tohoku University Graduate School of Medicine, Seiryo-machi 2-1, Sendai 980-8575.
Nicolas SaxFrom the Department of Biochemistry and CREST, Japan Science and Technology Agency, Seiryo-machi 2-1, Sendai 980-8575.
Shinya TajimaFrom the Department of Biochemistry and.
Andrey BrydunFrom the Department of Biochemistry and.
Tsuyoshi Ikurathe Radiation Biology Center, Kyoto University, Kyoto 606-8501.
Naoko YoshizawaTokyo Metropolitan Institute of Medical Sciences, Kamikitazawa 1-6, Tokyo 156-8506, and.
Hisao MasaiTokyo Metropolitan Institute of Medical Sciences, Kamikitazawa 1-6, Tokyo 156-8506, and.
Yutaka Hoshikawathe Japanese Foundation for Cancer Research, Cancer Institute, Ariake 3-10-6, Tokyo 135-8550, Japan.
Tetsuo Nodathe Japanese Foundation for Cancer Research, Cancer Institute, Ariake 3-10-6, Tokyo 135-8550, Japan.
Masaki Niothe Department of Pediatric Surgery, Tohoku University Graduate School of Medicine, Seiryo-machi 1-1, Sendai 980-0874.
Kyoko OchiaiFrom the Department of Biochemistry and CREST, Japan Science and Technology Agency, Seiryo-machi 2-1, Sendai 980-8575.
Kazuhiko IgarashiFrom the Department of Biochemistry and CREST, Japan Science and Technology Agency, Seiryo-machi 2-1, Sendai 980-8575, Center for Regulatory Epigenome and Diseases,Tohoku University Graduate School of Medicine, Seiryo-machi 2-1, Sendai 980-8575, igarashi@med.tohoku.ac.jp.ORCID http://orcid.org/0000-0002-2470-2475
Japan Science and Technology Agency · JPTohoku University · JPJapanese Foundation For Cancer Research · JPInstitute of Medical Sciences · INKyoto University · JPTokyo Metropolitan Institute of Medical Science · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

B lymphocyte-induced maturation protein 1 (Blimp-1) encoded by Prdm1 is a master regulator of plasma cell differentiation. The transcription factor Bach2 represses Blimp-1 expression in B cells to stall terminal differentiation, by which it supports reactions such as class switch recombination of the antibody genes. We found that histones H3 and H4 around the Prdm1 intron 5 Maf recognition element were acetylated at higher levels in X63/0 plasma cells expressing Blimp-1 than in BAL17 mature B cells lacking its expression. Conversely, methylation of H3-K9 was lower in X63/0 cells than BAL17 cells. Purification of the Bach2 complex in BAL17 cells revealed its interaction with histone deacetylase 3 (HDAC3), nuclear co-repressors NCoR1 and NCoR2, transducin β-like 1X-linked (Tbl1x), and RAP1-interacting factor homolog (Rif1). Chromatin immunoprecipitation confirmed the binding of HDAC3 and Rif1 to the Prdm1 locus. Reduction of HDAC3 or NCoR1 expression by RNA interference in B cells resulted in an increased Prdm1 mRNA expression. Bach2 is suggested to cooperate with HDAC3-containing co-repressor complexes in B cells to regulate the stage-specific expression of Prdm1 by writing epigenetic modifications at the Prdm1 locus.

Indexed as

Gene SilencingAcetylationAnimalsBasic-Leucine Zipper Transcription FactorsB-LymphocytesCell Line, TumorEpigenesis, GeneticHEK293 CellsHistone Deacetylase 3Histone DeacetylasesHistonesHumansMiceNuclear Receptor Co-Repressor 1Positive Regulatory Domain I-Binding Factor 1Promoter Regions, GeneticBach2 protein, mouseBasic-Leucine Zipper Transcription FactorsHistone Deacetylase 3Histone DeacetylasesHistonesNcor1 protein, mouseNuclear Receptor Co-Repressor 1Positive Regulatory Domain I-Binding Factor 1Prdm1 protein, mouseRif1 protein, mouseTelomere-Binding ProteinsTranscription FactorsacetylationB cellsepigeneticsgene regulationhistonemethylationplasma cellstranscription factor

Identifiers

PMID26786103
PMCPMC4813568
OpenAlexW2289400000

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.